PARADISE-MI suggests a limited role of intensified neuro-hormonal inhibition in the management of acute myocardial infarction with reduced ejection fraction

Affiliations

¹ Department of Cardiology, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Largo A. Gemelli 8, Rome 00168, Italy.
² Department of Clinical and Molecular Medicine, Sapienza University of Rome, Sant' Andrea Hospital, Via di Grottarossa, 1035-1039, Rome 00189, Italy.

Comment

Giovanna Liuzzo et al. Eur Heart J. 2022.

. 2022 Feb 12;43(7):559-560.

doi: 10.1093/eurheartj/ehab861.

¹ Department of Cardiology, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Largo A. Gemelli 8, Rome 00168, Italy.
² Department of Clinical and Molecular Medicine, Sapienza University of Rome, Sant' Andrea Hospital, Via di Grottarossa, 1035-1039, Rome 00189, Italy.

No abstract available

Comment on

Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
Pfeffer MA, Claggett B, Lewis EF, Granger CB, Køber L, Maggioni AP, Mann DL, McMurray JJV, Rouleau JL, Solomon SD, Steg PG, Berwanger O, Cikes M, De Pasquale CG, East C, Fernandez A, Jering K, Landmesser U, Mehran R, Merkely B, Vaghaiwalla Mody F, Petrie MC, Petrov I, Schou M, Senni M, Sim D, van der Meer P, Lefkowitz M, Zhou Y, Gong J, Braunwald E; PARADISE-MI Investigators and Committees. Pfeffer MA, et al. N Engl J Med. 2021 Nov 11;385(20):1845-1855. doi: 10.1056/NEJMoa2104508. N Engl J Med. 2021. PMID: 34758252 Clinical Trial.

Long-term use of renin-angiotensin-system inhibitors after acute myocardial infarction is not associated with survival benefits: Analysis of data from the Korean acute myocardial infarction registry-national institutes of health registry.
Park CS, Yang HM, Kang J, Han JK, Park KW, Kang HJ, Koo BK, Seung KB, Cha KS, Seong IW, Rha SW, Jeong MH, Kim HS. Park CS, et al. Front Cardiovasc Med. 2022 Aug 31;9:994419. doi: 10.3389/fcvm.2022.994419. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36119742 Free PMC article.
Efficacy of early administration of sacubitril/valsartan after coronary artery revascularization in patients with acute myocardial infarction complicated by moderate-to-severe mitral regurgitation: a randomized controlled trial.
Yin H, Ma L, Zhou Y, Tang X, Li R, Zhou Y, Shi J, Zhang J. Yin H, et al. Heart Vessels. 2024 Aug;39(8):673-686. doi: 10.1007/s00380-024-02398-2. Epub 2024 Apr 18. Heart Vessels. 2024. PMID: 38635062 Clinical Trial.
The PARADISE-MI trial: a new opportunity to improve the left ventricular remodelling in reperfused STEMI.
Bellis A, Mauro C, Barbato E, Trimarco B, Morisco C. Bellis A, et al. ESC Heart Fail. 2022 Dec;9(6):3698-3701. doi: 10.1002/ehf2.14159. Epub 2022 Sep 20. ESC Heart Fail. 2022. PMID: 36127281 Free PMC article. No abstract available.